Retina

Ambulatory surgical centers are freestanding health care facilities that specialize in providing surgical and diagnostic procedures, not requiring an overnight stay.

This treatment is already approved for both diabetic macular edema (DME) and NIU-PS outside the US, including in 17 European countries.

The authors commented that the patient’s "age, relative acute onset, and lack of medical history make this an atypical presentation.”

Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography

Maria Vittoria Cicinelli, MD, Denise Loya-Garcia, MD, PhD, and Vishal Raval, MD, were announced as the recipients and will receive a $3,000 honorarium.

The award honors Ludwig von Sallmann, MD, a “distinguished international ophthalmologist and ophthalmic investigator whose contributions greatly increased the basic and clinical understanding of vision and ophthalmology.”

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

The retinal implant delivers continuous neurotrophic support, potentially halting disease progression and paving the way for future treatments in neurodegenerative retinal disorders.

A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden

Tarcocimab is an investigational anti-VEGF therapy built on Kodiak's proprietary antibody biopolymer conjugate (ABC) platform.

Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease

This database could enhance the workflow of eye care professionals with its in-depth reference data for retinal layer thickness and optic nerve head metrics.

ENCELTO is the first and only FDA-approved treatment for MacTel.

In a keynote speech, Warren Hoburg and Tyson J. Brunstetter, OD, PhD, will discuss in-orbit imaging and spaceflight-associated neuro-ocular syndrome

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

ENCELTO is the first and only FDA-approved treatment for MacTel.

Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and chronic allergic and inflammatory conditions affecting the eye.

The negative effects of smoking on ocular tissues are well known and include age-related macular degeneration (AMD), diabetic retinopathy, cataracts, contact lens-related keratitis, Graves’ ophthalmopathy ischemic optic neuropathy, and glaucoma.

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease

PYK-2101 is a first-in-class biodegradable retinal hydrogel sealant.

One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom

The investigators' findings suggest that CVI is a valuable noninvasive predictive biomarker for monitoring vascular changes in patients who smoke

The investigators set out to identify a correlation between the TyG index in CRAO in patients who had been newly diagnosed with the disease.